Skip to main content
. 2021 Apr 7;12:653836. doi: 10.3389/fimmu.2021.653836

Figure 1.

Figure 1

Analysis of survival and Tumor mutation burden (TMB) associated with immune/stromal/Estimate scores and tumor purity. (A) Kaplan–Meier survival analysis based on immune/stromal/Estimate/scores and tumor purity. Overall survival (OS), disease-specific survival (DSS), disease-free interval (DFI), progression-free interval (PFI). (B) The relationship of immune/stromal/Estimate/scores and tumor purity with tumor mutation burden (TMB). The samples were divided into high and low groups according to the median of score. *p < 0.05, **p < 0.01, and ***p < 0.001 between the two groups.